Guillain-Barré Syndrome (GBS), a rare but potentially serious autoimmune disorder, has seen an alarming rise in cases in India recently. This condition, which attacks the peripheral nervous system, can lead to muscle weakness, paralysis, and other severe complications. For corporates, the implications of increasing GBS cases extend beyond individual employees